Exome Sequencing, not WGS, May ID Causative Mutations in Vast Majority of Mendelian Disease | GenomeWeb

NEW YORK (GenomeWeb) – With more than 12,200 exomes sequenced, the three Centers for Mendelian Genetics funded by the National Human Genome Research Center have identified novel genes causative of more than 200 disorders and continue to provide evidence that exome sequencing, not whole-genome sequencing, is the more efficient tool for studying Mendelian disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.